Mirum Pharmaceuticals, Inc.: cashflow_operating
| Value | {"amount": -228763000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"} |
|---|---|
| Period | 2026-01-01 – 2026-03-31 |
| Status | current |
| Entity | Mirum Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:53:37.700410+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/df8ca5d1-53f5-4599-9e10-6557a810ad45
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001759425-26-000037Retrieved: 2026-08-19T17:53:37.700410+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001759425/cashflow-operating/2026-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/df8ca5d1-53f5-4599-9e10-6557a810ad45
History
- no predecessors — first report